$HLYK Income Statement | Understand Stock

$HLYK

$2.60 -$0.05 (1.81%) Close

$HLYK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Patient service revenue, net
Subscription revenue
Product revenue
Total revenue
Medicare shared savings revenue
Consulting and event revenue
Subscription and event revenue

Operating Expenses and Costs
Practice salaries and benefits
Other practice operating expenses
Cost of product revenue
Selling, general and administrative expenses
Depreciation and amortization
Interest income (expense)
Impairment loss
Total Operating Expenses and Costs
Loss from operations
Loss from operations

Other Income (Expenses)
Gain (loss) on extinguishment of debt
Change in fair value of debt
Financing cost
Gain (loss) on change in fair value of debt
Gain from expiration of liability classified equity instruments
Gain on sale of assets
Amortization of original issue discounts on notes payable
Gain from realization of contingent sale consideration receivable
Change in fair value of contingent acquisition consideration
Interest expense and other
Total other income (expenses)
Loss before provision for income taxes
Loss from operations of discontinued operations
Gain from disposal of discontinued operations
Net loss
Deemed dividend - amortization of beneficial conversion feature
Net loss to common shareholders
Net loss per share, basic and diluted:
Basic (in Dollars per share)
Basic (in Dollars per share)
Basic (in Dollars per share)
Fully diluted (in Dollars per share)
Weighted average number of common shares:
Basic (in Shares)
Fully diluted (in Shares)

Comments